Literature DB >> 10218766

Ferritin-associated iron induces neutrophil dysfunction in hemosiderosis.

B Cantinieaux1, A Janssens, J R Boelaert, M Lejeune, C Vermylen, V Kerrels, G Cornu, J Winand, P Fondu.   

Abstract

Neutrophils (PMNs) from patients with secondary iron overload have an increased iron and ferritin content as well as a phagocytosis defect. Several serum components might be incriminated in the cellular iron accumulation. We therefore compared the effects on the PMN phagocytosis of total serum as well as the ferritin and transferrin fractions of serum derived from patients with thalassemia major and healthy control subjects. An incubation system of PMNs was developed. PMN phagocytosis was measured before and after incubation. Total serum from patients with thalassemia induced a defect that was prevented by co-incubation with deferoxamine (DFO). Gel-filtration chromatography was performed to separate the serum fraction containing transferrin and albumin from that containing ferritin. The transferrin-albumin fraction had no effect on PMN phagocytosis. On the contrary, the ferritin fraction of normal serum was deleterious to PMN phagocytosis, and the same fraction from thalassemic serum decreased PMN phagocytosis even more. Co-incubation with DFO or catalase improved this defect. Moreover, a cellular increase in the L-type subunit of ferritin was observed after the incubation of PMNs with the ferritin-containing fraction from thalassemic serum. In conclusion, serum from patients with thalassemia is toxic to PMNs, and this toxicity is due to ferritin-associated iron.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218766     DOI: 10.1016/s0022-2143(99)90066-5

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

1.  Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis.

Authors:  Teclegiorgis Gebremariam; Lin Lin; Mingfu Liu; Dimitrios P Kontoyiannis; Samuel French; John E Edwards; Scott G Filler; Ashraf S Ibrahim
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

Review 2.  Host cell invasion in mucormycosis: role of iron.

Authors:  Ashraf S Ibrahim
Journal:  Curr Opin Microbiol       Date:  2011-07-30       Impact factor: 7.934

Review 3.  Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis.

Authors:  Laura C García-Carnero; Héctor M Mora-Montes
Journal:  J Fungi (Basel)       Date:  2022-04-25

Review 4.  Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.

Authors:  Salah Mohamed El Sayed; Hussam Baghdadi; Ashraf Abou-Taleb; Hany Salah Mahmoud; Reham A Maria; Nagwa S Ahmed; Manal Mohamed Helmy Nabo
Journal:  J Blood Med       Date:  2014-10-30

5.  COVID-19 Associated Mucormycosis (CAM): A Single Hospital-Based Study.

Authors:  Manjunath M Vijapur; Vasanth Kattimani; V K Varsha; H C Girish; Mamata Kamat; Bhargav Ram
Journal:  J Oral Maxillofac Pathol       Date:  2022-06-28

6.  Evaluation of immune system in patients with transfusion-dependent beta-thalassemia in Rasoul-e-Akram Hospital in 2021: A descriptive cross-sectional study.

Authors:  Fahime Ehsanipour; Pooya Faranoush; Mohammad Reza Foroughi-Gilvaee; Negin Sadighnia; Morteza Fallahpour; Mona Motamedi; Afsoon Zandi; Zahra Safaei; Ashkan Zandi; Mohammad Faranoush
Journal:  Health Sci Rep       Date:  2022-10-03

Review 7.  Molecular mechanisms of mucormycosis-The bitter and the sweet.

Authors:  Clara Baldin; Ashraf S Ibrahim
Journal:  PLoS Pathog       Date:  2017-08-03       Impact factor: 7.464

Review 8.  Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes.

Authors:  Omer Sefvan Janjua; Muhammad Saad Shaikh; Muhammad Amber Fareed; Sana Mehmood Qureshi; Muhammad Ikram Khan; Danya Hashem; Muhammad Sohail Zafar
Journal:  J Fungi (Basel)       Date:  2021-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.